A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Dana-Farber Cancer Institute
Iovance Biotherapeutics, Inc.
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
British Columbia Cancer Agency
The Center for Clinical and Cosmetic Research